Voleon Capital Management’s Idexx Laboratories IDXX Stock Holding History

Voleon Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.79M	Buy	10,993 +8,701	+380%	+$4.88M	0.11%	193
2026 Q1	$1.29M	Buy	+2,292	New	+$1.47M	0.03%	401
2025 Q4	–	Sell	-1,099	Closed	-$702K	–	900
2025 Q3	$702K	Buy	1,099 +475	+76%	+$288K	0.02%	510
2025 Q2	$335K	Sell	624 -2,308	-79%	-$1.1M	0.02%	385
2025 Q1	$1.23M	Sell	2,932 -5,371	-65%	-$2.33M	0.1%	178
2024 Q4	$3.43M	Buy	+8,303	New	+$3.64M	0.25%	101
2021 Q1	–	Sell	-12,000	Closed	-$6M	–	17
2020 Q4	$6M	Buy	+12,000	New	+$5.37M	0.64%	38
2019 Q3	–	Sell	-1,000	Closed	-$275K	–	190
2019 Q2	$275K	Buy	+1,000	New	+$246K	0.02%	173

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Voleon Capital Management's IDXX Position: Q2 2026 in Review

Voleon Capital Management increased its Idexx Laboratories (IDXX) stake by 380% in Q2 2026, buying an estimated $4.88M and bringing the position to 10,993 shares worth $5.79M. The position accounts for 0.11% of the portfolio, ranked #193.

Voleon Capital Management first reported a position in IDXX in Q2 2019 and has held it in 8 quarters since. The position peaked at $6M in Q4 2020. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Voleon Capital Management held 10,993 shares of Idexx Laboratories worth $5.79M as of Q2 2026.
Voleon Capital Management bought 8,701 Idexx Laboratories shares in Q2 2026, an estimated $4.88M.
Idexx Laboratories made up 0.11% of Voleon Capital Management's portfolio in Q2 2026, its #193 holding.
Voleon Capital Management first reported a position in Idexx Laboratories in Q2 2019 and has held it in 8 quarters since.
Voleon Capital Management's Idexx Laboratories position peaked at $6M in Q4 2020.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.